Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective comparison of sirolimus versus corticosteroids in active thyroid eye disease
2021-000641-41Phase 2Active
- Sponsor
- Helse Bergen
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sirolimus in Graves Orbitopathy (GO) and Graves' disease (2 arms), sponsored by Helse Bergen. Primary endpoint: Clinical response in Clinical Activity Score at week 12. Started Sep 2021; status: active.
02
Drugs
sirolimus
03
Conditions
Graves Orbitopathy (GO)Graves' disease
Beyond the preview
Go deeper on 2021-000641-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000641-41.